Skip to main content
. Author manuscript; available in PMC: 2023 Jun 8.
Published in final edited form as: Neuropsychology. 2022 Aug 4;37(4):409–423. doi: 10.1037/neu0000835

Table 1.

Demographic and Clinical Characteristics of the Legacy Studies at the Most Recent Study Visit

Variable ACT ADNI ROS MAP
Sample size, n 5,546 3,016 1,456 2,163
Age, mean (SD) 81.9 (7.8) 74.9 (8.7) 85.8 (7.4) 86.0 (7.9)
Female, (%) 58.2 48.1 71.6 73.5
Education, mean (SD) 14.9 (3.2) 16.1 (2.8) 18.4 (3.3) 14.9 (3.3)
Self-reported race, %
 Non-Latinx White 88.8 88.1 89.6 88.5
 African/American   3.6   4.6   5.7   5.2
 Hispanic/Latino   1.1   3.7   4.3   5.5
 Others   6.5   3.6   0.4   0.8
Cognitive diagnosis at most recent visit, %
 Cognitively normal 92.2 38.3 42.2 50.4
 Mild Cognitive Impairment (MCI) N/Aa 32.0 23.0 23.7
 Diagnosed with AD   6.0 29.7 33.4 24.5
 Other dementia   1.8 N/A   1.4   1.4

Note. ACT = adult changes in thought; ADNI = Alzheimer’s Disease Neuroimaging Initiative; ROS = Religious Orders Study; MAP = Memory and Aging Project; AD = Alzheimer’s disease; SD = standard deviation. A few individuals were missing some of these demographic characteristics.

a

In ACT, MCI as a diagnosis is generally not made.